These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33422676)

  • 81. Improvement of baculovirus as protein expression vector and as biopesticide by CRISPR/Cas9 editing.
    Pazmiño-Ibarra V; Mengual-Martí A; Targovnik AM; Herrero S
    Biotechnol Bioeng; 2019 Nov; 116(11):2823-2833. PubMed ID: 31403180
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficient Human Genome Editing Using SaCas9 Ribonucleoprotein Complexes.
    Wang Y; Wang B; Xie H; Ren Q; Liu X; Li F; Lv X; He X; Cheng C; Deng R; Li J; Zhao J; Song Z; Gu F
    Biotechnol J; 2019 Jul; 14(7):e1800689. PubMed ID: 30927491
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Near-Infrared Light Activated Formulation for the Spatially Controlled Release of CRISPR-Cas9 Ribonucleoprotein for Brain Gene Editing.
    Simões S; Lino M; Barrera A; Rebelo C; Tomatis F; Vilaça A; Breunig C; Neuner A; Peça J; González R; Carvalho A; Stricker S; Ferreira L
    Angew Chem Int Ed Engl; 2024 May; 63(21):e202401004. PubMed ID: 38497898
    [TBL] [Abstract][Full Text] [Related]  

  • 84. CRISPR/Cas9 genome editing in human hematopoietic stem cells.
    Bak RO; Dever DP; Porteus MH
    Nat Protoc; 2018 Feb; 13(2):358-376. PubMed ID: 29370156
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Lentiviral Capsid-Mediated
    Lu Z; Yao X; Lyu P; Yadav M; Yoo K; Atala A; Lu B
    CRISPR J; 2021 Dec; 4(6):914-928. PubMed ID: 33733873
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficient production of large deletion and gene fragment knock-in mice mediated by genome editing with Cas9-mouse Cdt1 in mouse zygotes.
    Mizuno-Iijima S; Ayabe S; Kato K; Matoba S; Ikeda Y; Dinh TTH; Le HT; Suzuki H; Nakashima K; Hasegawa Y; Hamada Y; Tanimoto Y; Daitoku Y; Iki N; Ishida M; Ibrahim EAE; Nakashiba T; Hamada M; Murata K; Miwa Y; Okada-Iwabu M; Iwabu M; Yagami KI; Ogura A; Obata Y; Takahashi S; Mizuno S; Yoshiki A; Sugiyama F
    Methods; 2021 Jul; 191():23-31. PubMed ID: 32334080
    [TBL] [Abstract][Full Text] [Related]  

  • 87. CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40.
    Wang R; Graham S; Sun N; McCarthy D; Peng R; Erickson J; Oconnor L; Zhu X; Wurbel M; Dunstan R; Westmoreland S; Chung N; Ghayur T; Gu J
    PLoS One; 2020; 15(3):e0228221. PubMed ID: 32155151
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Plasmid- or Ribonucleoprotein-Mediated CRISPR/Cas Gene Editing in Primary Murine T Cells.
    Dölz M; Marone R; Jeker LT
    Methods Mol Biol; 2021; 2285():255-264. PubMed ID: 33928558
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2.
    Thavalingam A; Cheng Z; Garcia B; Huang X; Shah M; Sun W; Wang M; Harrington L; Hwang S; Hidalgo-Reyes Y; Sontheimer EJ; Doudna J; Davidson AR; Moraes TF; Wang Y; Maxwell KL
    Nat Commun; 2019 Jun; 10(1):2806. PubMed ID: 31243272
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Variation in zygotic CRISPR/Cas9 gene editing outcomes generates novel reporter and deletion alleles at the Gdf11 locus.
    Goldstein JM; Valido A; Lewandowski JP; Walker RG; Mills MJ; Messemer KA; Besseling P; Lee KH; Wattrus SJ; Cho M; Lee RT; Wagers AJ
    Sci Rep; 2019 Dec; 9(1):18613. PubMed ID: 31819086
    [TBL] [Abstract][Full Text] [Related]  

  • 91. CRISPR/Cas9-mediated genome editing in sea urchins.
    Lin CY; Oulhen N; Wessel G; Su YH
    Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells.
    Vakulskas CA; Dever DP; Rettig GR; Turk R; Jacobi AM; Collingwood MA; Bode NM; McNeill MS; Yan S; Camarena J; Lee CM; Park SH; Wiebking V; Bak RO; Gomez-Ospina N; Pavel-Dinu M; Sun W; Bao G; Porteus MH; Behlke MA
    Nat Med; 2018 Aug; 24(8):1216-1224. PubMed ID: 30082871
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Editing the genome of Aphanomyces invadans using CRISPR/Cas9.
    Majeed M; Soliman H; Kumar G; El-Matbouli M; Saleh M
    Parasit Vectors; 2018 Oct; 11(1):554. PubMed ID: 30352624
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
    Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
    Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
    [TBL] [Abstract][Full Text] [Related]  

  • 95. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Mature Primary Innate Immune Cells.
    Riggan L; Hildreth AD; Rolot M; Wong YY; Satyadi W; Sun R; Huerta C; O'Sullivan TE
    Cell Rep; 2020 May; 31(7):107651. PubMed ID: 32433960
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Lipopeptide-Based Nanosome-Mediated Delivery of Hyperaccurate CRISPR/Cas9 Ribonucleoprotein for Gene Editing.
    Thach TT; Bae DH; Kim NH; Kang ES; Lee BS; Han K; Kwak M; Choi H; Nam J; Bae T; Suh M; Hur JK; Kim YH
    Small; 2019 Nov; 15(46):e1903172. PubMed ID: 31588686
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Optimized Guide RNA Selection Improves
    Verhagen HJMP; Kuijk C; Rutgers L; Kokke AM; van der Meulen SA; van Mierlo G; Voermans C; van den Akker E
    CRISPR J; 2022 Oct; 5(5):702-716. PubMed ID: 36169633
    [TBL] [Abstract][Full Text] [Related]  

  • 98. CRISPR: From Prokaryotic Immune Systems to Plant Genome Editing Tools.
    Bandyopadhyay A; Mazumdar S; Yin X; Quick WP
    Adv Exp Med Biol; 2017; 1016():101-120. PubMed ID: 29130156
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Duplex CRISPR-Cas9 Ribonucleoprotein Nanomedicine for Colorectal Cancer Gene Therapy.
    Wan T; Pan Q; Liu C; Guo J; Li B; Yan X; Cheng Y; Ping Y
    Nano Lett; 2021 Nov; 21(22):9761-9771. PubMed ID: 34767372
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects.
    Deng S; Li X; Liu S; Chen J; Li M; Chew SY; Leong KW; Cheng D
    Sci Adv; 2020 Jul; 6(29):eabb4005. PubMed ID: 32832641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.